3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
100
INDUSTRY
38
NIH
7
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
1
Interventions
Drug Therapy
10
pembrolizumab
9
Bevacizumab
9
Radiotherapy
8
Cyclophosphamide
8
Carboplatin
8
Oxaliplatin
7
tislelizumab
6
Surgical Procedures, Operative
6
Docetaxel
6
Cisplatin
6
Capecitabine
6
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Control Groups
5
fludarabine
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Endoscopic Mucosal Resection
4
sintilimab
3
Trastuzumab
3
Pemetrexed
3
Neoadjuvant Therapy
3
Leucovorin
3
Laparoscopy
3
Irinotecan
3
Injections
3
Hematologic Tests
3
HMPL-013
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
atezolizumab
×
Clear all
NCT07293468
2026-04-09
BIIRTH
Tuen Mun Hospital
Phase 2/3
Recruiting
106 enrolled